Verification study of the new peripheral intravenous catheter
- Conditions
- Diseases which are needed administration of stimulating drugs
- Registration Number
- JPRN-jRCTs032210224
- Lead Sponsor
- Mineo Kurokawa
- Brief Summary
This study confirmed the effectiveness of CF reduction by using a new catheter placed on the upper arm vein compared to a short catheter placed on the forearm vein for patients administered irritant drugs. New catheters did not increase the incidence of adverse events and lead to treatment interruption due to device malfunction.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Patients must satisfy the followings; .
1) Patients are scheduled to administrate stimulant drugs using peripheral intravenous catheter.
2) Over 19 years, regardless of gender
3) Patients are scheduled to continuous infusion therapy over 24 hours
4) Patients give us their written consent for the study
5) The first catheterization at this hospitalization
The following patients must be excluded.
1) Patients are unable to maintain the position to fully rotate the shoulder joint and rotate the elbow joint
2) Having skin disorders at the puncture site
3) Having peripheral neuropathy
4) Having a history of vasovagal reflex due to puncture
5) Having a history of thrombosis
6) With end-stage renal disease (stage 2 or higher)
7) Having abnormal blood coagulation or bleeding tendency (PT-INR 1.5 or more, APTT 36.1 seconds or more, while taking any anticoagulant or antiplatelet drugs)
8) Patient is planned of highly invasive tests (endoscopy, bronchoscopy)
9) Participation of this study is judged inappropriate for patient by physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The incidence rate of catheter failures (%)
- Secondary Outcome Measures
Name Time Method 1) The incidence rate of catheter failures per 1000 days<br>2) Presence or absence of a thrombus in the vessel and a subcutaneous edema<br>3) Signs and symptoms such as redness, swelling, induration and occulusion<br>4) Subjective evaluation of catheter placement